Area of research
Molecular Medicine · Pharmacology
Research interest
Research focused on Microbiology and Ceftazidime/avibactam, with related work in Acinetobacter baumannii, Antibiotic resistance, Klebsiella pneumoniae. Notable publications include 'Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014', 'Current Status and Trends of Antibacterial Resistance in China', and 'Resistance reported from China antimicrobial surveillance network (CHINET) in 2018'.
Antimicrobial resistance profile of clinical isolates from hospitals across China: CHINET 2024 surveillance report
Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistance
A multicentre, randomised, double-blind, double-dummy, parallel-controlled, phase 3 clinical trial assessing the efficacy and safety of intravenous nemonoxacin malate vs. levofloxacin for community-acquired pneumonia in adult patients
Current status and trends of antimicrobial resistance among clinical isolates in China: a retrospective study of CHINET from 2018 to 2022
<i>In Vitro</i> Activity of New β-Lactam–β-Lactamase Inhibitor Combinations and Comparators against Clinical Isolates of Gram-Negative Bacilli: Results from the China Antimicrobial Surveillance Network (CHINET) in 2019
A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET)
A randomized, controlled, multicenter clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus moxifloxacin in adult patients with community-acquired pneumonia
<i>In Vitro</i> Activity of Cefepime-Zidebactam, Ceftazidime-Avibactam, and Other Comparators against Clinical Isolates of <i>Enterobacterales</i> , Pseudomonas aeruginosa, and Acinetobacter baumannii: Results from China Antimicrobial Surveillance Network (CHINET) in 2018
Resistance reported from China antimicrobial surveillance network (CHINET) in 2018
Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the <i>In Vitro</i> Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of <i>Enterobacteriaceae</i> and <i>Pseudomonas aeruginosa</i>
Current Status and Trends of Antibacterial Resistance in China
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014
High Prevalence of <i>vanM</i> in Vancomycin-Resistant Enterococcus faecium Isolates from Shanghai, China
A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia
Mechanisms of Tigecycline Resistance among Klebsiella pneumoniae Clinical Isolates
Comparison of Adhesin Genes and Antimicrobial Susceptibilities between Uropathogenic and Intestinal Commensal Escherichia coli Strains
Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study
Hospital clonal dissemination of Enterobacter aerogenes producing carbapenemase KPC-2 in a Chinese teaching hospital